Here, we assessed the correlation between IGF-1R inhibition and HR functionality of breast and ovarian cancers cells, and observed an increased sensitivity of HR deficient cancer cells to IGF-1Rki. The gene discussed is IGF1R; the disease is ovarian carcinoma.